Osteochondral Tissue-On-a-Chip: A Novel Model for Osteoarthritis Research
- PMID: 39337321
- PMCID: PMC11432185
- DOI: 10.3390/ijms25189834
Osteochondral Tissue-On-a-Chip: A Novel Model for Osteoarthritis Research
Abstract
The existing in vitro and in vivo models for studying osteoarthritis have significant limitations in replicating the complexity of joint tissues. This research aims to validate a Tissue-On-a-Chip system for osteoarthritis research. Osteochondral tissues obtained from knee replacement surgeries of patients with osteoarthritis were cultured in an Organ-On-a-Chip system. This system was designed to supply oxygen and glucose to the cartilage from the bone. The distribution of oxygen and glucose was evaluated by fluorescence using Image-iT Green Hypoxia and 2-NBDG, respectively. Cytotoxicity was measured using lactate dehydrogenase (LDH) levels in chip cultures compared to plate cultures (12 tissues per method). Glycosaminoglycans (GAGs), alkaline phosphatase (ALP), Coll2-1, and procollagen type II N-terminal propeptide (PIINP) were measured in the perfused medium of the Tissue-On-a-Chip over a period of 70 days. Fluorescence of Image-iT Green Hypoxia was observed only in the cartilage area, while 2-NBDG was distributed throughout the tissue. An increase in LDH levels was noted in the plate cultures on day 24 and in the Tissue-On-a-Chip cultures on day 63. Compared to the start of the culture, GAG content increased on day 52, while ALP showed variations. A notable increase in GAG, ALP, and Coll2-1 levels was observed on day 59. PIINP levels remained stable throughout the experiment. The validated osteochondral Tissue-On-a-Chip system can replicate the joint microenvironment, with hypoxic conditions in cartilage and normoxic conditions in bone. Tissue survival and component stability were maintained for approximately two months. This platform is a useful tool for evaluating new drugs and represents a viable alternative to animal models.
Keywords: Joint-On-a-Chip; Organ-On-a-Chip; Tissue-On-a-Chip; bone; cartilage; osteoarthritis; osteochondral tissue.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




Similar articles
-
Non-destructive monitoring of viability in an ex vivo organ culture model of osteochondral tissue.Eur Cell Mater. 2015 Jun 30;29:356-69; discussion 369. doi: 10.22203/ecm.v029a27. Eur Cell Mater. 2015. PMID: 26122871
-
Osteoarthritis in the temporo-mandibular joint (TMJ) of aged mice and the in vitro effect of TGF-beta 1 on cell proliferation, matrix synthesis, and alkaline phosphatase activity.Microsc Res Tech. 1997 May 15;37(4):314-23. doi: 10.1002/(SICI)1097-0029(19970515)37:4<314::AID-JEMT6>3.0.CO;2-K. Microsc Res Tech. 1997. PMID: 9185153
-
A human osteoarthritis osteochondral organ culture model for cartilage tissue engineering.Biomaterials. 2018 Apr;162:1-21. doi: 10.1016/j.biomaterials.2018.02.002. Epub 2018 Feb 4. Biomaterials. 2018. PMID: 29428675
-
Three-dimensional osteochondral microtissue to model pathogenesis of osteoarthritis.Stem Cell Res Ther. 2013;4 Suppl 1(Suppl 1):S6. doi: 10.1186/scrt367. Epub 2013 Dec 20. Stem Cell Res Ther. 2013. PMID: 24564995 Free PMC article. Review.
-
Autologous tissue transplantations for osteochondral repair.Dan Med J. 2016 Apr;63(4):B5236. Dan Med J. 2016. PMID: 27034191 Review.
Cited by
-
Collection, Establishment and Assessment of Complex Human Osteocartilaginous Explants for Modeling Osteoarthritis.Biomedicines. 2024 Oct 21;12(10):2406. doi: 10.3390/biomedicines12102406. Biomedicines. 2024. PMID: 39457719 Free PMC article.
-
Applications in osteochondral organoids for osteoarthritis research: from pathomimetic modeling to tissue engineering repair.Front Bioeng Biotechnol. 2025 Jul 23;13:1629608. doi: 10.3389/fbioe.2025.1629608. eCollection 2025. Front Bioeng Biotechnol. 2025. PMID: 40771720 Free PMC article. Review.
References
-
- Cross M., Smith E., Hoy D., Nolte S., Ackerman I., Fransen M., Bridgett L., Williams S., Guillemin F., Hill C.L., et al. The global burden of hip and knee osteoarthritis: Estimates from the Global Burden of Disease 2010 study. Ann. Rheum. Dis. 2014;73:1323–1330. doi: 10.1136/annrheumdis-2013-204763. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical